<DOC>
	<DOCNO>NCT00990301</DOCNO>
	<brief_summary>The purpose study evaluate relative bioavailability Paddock Laboratories , Inc. 's test formulation Moexipril/ Hydrochlorothiazide 15mg/25mg tablet reference formulation UnireticÂ® ( Moexipril/ Hydrochlorothiazide ) 15mg/25mg tablet , fast condition .</brief_summary>
	<brief_title>A Study Compare Relative Bioavailability Moexipril HCl/Hydrochlorothiazide Healthy Adult Volunteers Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Moexipril</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Good health determine lack clinically significant abnormality health assessment perform screen Positive test result HIV Hepatitis B C History allergy sensitivity Moexipril , Hydrochlorothiazide relate drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Healthy Subjects</keyword>
	<keyword>Bioequivalence</keyword>
</DOC>